This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
TLR signaling that induces weak inflammatory response and SHIP1 enhances osteogenic functions
Bone Research Open Access 11 November 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Shinohara, M. et al. The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss. Bone 10.1016/j.bone.2013.11.025
Rights and permissions
About this article
Cite this article
Jones, B. Regulating osteoclast differentiation to prevent bone loss. Nat Rev Rheumatol 10, 66 (2014). https://doi.org/10.1038/nrrheum.2013.206
Published:
Issue date:
DOI: https://doi.org/10.1038/nrrheum.2013.206